| 27/04/26 | 12:00:02 | 27 Apr 2026 | | Efimosfermin granted US/EU regulatory designations |
| 27/04/26 | 07:00:09 | 27 Apr 2026 | | TESARO update on AnaptysBio Inc. litigation |
| 24/04/26 | 15:30:00 | 24 Apr 2026 | | Director/PDMR Shareholding |
| 23/04/26 | 07:00:04 | 23 Apr 2026 | | Transaction in Own Shares |
| 22/04/26 | 07:00:02 | 22 Apr 2026 | | Transaction in Own Shares |
| 21/04/26 | 07:00:03 | 21 Apr 2026 | | Transaction in Own Shares |
| 20/04/26 | 15:30:01 | 20 Apr 2026 | | Director/PDMR Shareholding |
| 20/04/26 | 07:00:05 | 20 Apr 2026 | | Blenrep approved in China for 2L+ multiple myeloma |
| 20/04/26 | 07:00:04 | 20 Apr 2026 | | Transaction in Own Shares |
| 17/04/26 | 07:00:03 | 17 Apr 2026 | | Transaction in Own Shares |
| 16/04/26 | 15:30:01 | 16 Apr 2026 | | Director/PDMR Shareholding |
| 16/04/26 | 07:00:02 | 16 Apr 2026 | | Transaction in Own Shares |
| 15/04/26 | 07:12:06 | 15 Apr 2026 | | GSK completes acquisition of 35Pharma Inc. |
| 15/04/26 | 07:00:04 | 15 Apr 2026 | | Transaction in Own Shares |
| 14/04/26 | 15:30:00 | 14 Apr 2026 | | Director/PDMR Shareholding |
| 14/04/26 | 07:00:02 | 14 Apr 2026 | | Transaction in Own Shares |
| 13/04/26 | 15:30:00 | 13 Apr 2026 | | Director/PDMR Shareholding |
| 13/04/26 | 07:00:05 | 13 Apr 2026 | | Transaction in Own Shares |
| 13/04/26 | 07:00:04 | 13 Apr 2026 | | GSK presents positive data for BEHOLD 1 B7 H4 ADC |
| 10/04/26 | 15:30:00 | 10 Apr 2026 | | Director/PDMR Shareholding |
| 10/04/26 | 07:00:04 | 10 Apr 2026 | | Transaction in Own Shares |
| 09/04/26 | 15:30:01 | 9 Apr 2026 | | Director/PDMR Shareholding |
| 09/04/26 | 07:00:03 | 9 Apr 2026 | | Transaction in Own Shares |
| 08/04/26 | 07:00:09 | 8 Apr 2026 | | Exdensur approved for CRSwNP in China |
| 08/04/26 | 07:00:04 | 8 Apr 2026 | | Transaction in Own Shares |
| 07/04/26 | 07:00:05 | 7 Apr 2026 | | Transaction in Own Shares |
| 02/04/26 | 07:00:02 | 2 Apr 2026 | | Transaction in Own Shares |
| 01/04/26 | 15:30:01 | 1 Apr 2026 | | Director/PDMR Shareholding |
| 01/04/26 | 15:00:00 | 1 Apr 2026 | | Total Voting Rights |
| 01/04/26 | 07:00:08 | 1 Apr 2026 | | ViiV completes changes to minority shareholding |
| 01/04/26 | 07:00:05 | 1 Apr 2026 | | Transaction in Own Shares |
| 31/03/26 | 07:00:03 | 31 Mar 2026 | | Transaction in Own Shares |
| 30/03/26 | 07:05:00 | 30 Mar 2026 | | Bepirovirsen accepted for review in China |
| 30/03/26 | 07:00:13 | 30 Mar 2026 | | Exdensur approved for severe asthma in China |
| 30/03/26 | 07:00:07 | 30 Mar 2026 | | Transaction in Own Shares |
| 27/03/26 | 07:00:08 | 27 Mar 2026 | | Bepirovirsen accepted for review by the EMA |
| 27/03/26 | 07:00:03 | 27 Mar 2026 | | Transaction in Own Shares |
| 26/03/26 | 07:00:04 | 26 Mar 2026 | | Transaction in Own Shares |
| 25/03/26 | 15:30:00 | 25 Mar 2026 | | Director/PDMR Shareholding |
| 25/03/26 | 13:00:00 | 25 Mar 2026 | | Notice of AGM |
| 25/03/26 | 07:00:05 | 25 Mar 2026 | | Transaction in Own Shares |
| 24/03/26 | 07:00:07 | 24 Mar 2026 | | Transaction in Own Shares |
| 23/03/26 | 15:30:01 | 23 Mar 2026 | | Director/PDMR Shareholding |
| 23/03/26 | 15:00:00 | 23 Mar 2026 | | Admission to Trading |
| 23/03/26 | 07:00:13 | 23 Mar 2026 | | GSK Lung Cancer ADC Gets Japan Orphan Drug Status |
| 23/03/26 | 07:00:06 | 23 Mar 2026 | | Transaction in Own Shares |
| 20/03/26 | 07:00:06 | 20 Mar 2026 | | Transaction in Own Shares |
| 19/03/26 | 12:00:00 | 19 Mar 2026 | | Lynavoy (linerixibat) approved by US FDA |
| 19/03/26 | 07:00:09 | 19 Mar 2026 | | Transaction in Own Shares |
| 18/03/26 | 15:30:01 | 18 Mar 2026 | | Director/PDMR Shareholding |